PRECIGEN, INC.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows for the and
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| (Amounts in thousands) | 2026 | 2025 |
| Cash flows from operating activities | ||
| Net income (loss) | $47,908 | $(227,139) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 3,311 | 2,062 |
| Loss on disposals of assets, net | — | 14 |
| Impairment of goodwill | — | 3,907 |
| Change in fair value of warrant liabilities | — | 139,523 |
| Amortization of discounts on investments, net | (748) | (1,492) |
| Stock-based compensation expense | 10,363 | 8,703 |
| Shares issued as payment for services | 526 | 527 |
| Accretion of debt discount and amortization of deferred financing costs | 1,082 | 72 |
| Other noncash items | (2) | — |
| Changes in operating assets and liabilities: | ||
| Receivables: | ||
| Trade | (92,570) | 346 |
| Other | 313 | (283) |
| Inventory | (13,334) | (2,948) |
| Prepaid expenses | (2,723) | (962) |
| Other assets | 274 | (382) |
| Accounts payable | (5,561) | 2,232 |
| Accrued compensation and benefits | 1,026 | 6,629 |
| Other accrued liabilities | 3,416 | 6,610 |
| Deferred revenue | (343) | (1,948) |
| Lease liabilities | (129) | (5) |
| Indemnification accruals | (2,476) | — |
| Other long-term liabilities | (86) | 163 |
| Net cash used in operating activities | (49,753) | (64,371) |
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| (Amounts in thousands) | 2026 | 2025 |
| Cash flows from investing activities | ||
| Purchases of investments | $(150,042) | $(184,146) |
| Sales and maturities of investments | 184,810 | 144,722 |
| Purchases of property, plant and equipment | (1,085) | (1,977) |
| Net cash provided by (used in) investing activities | 33,683 | (41,401) |
| Cash flows from financing activities | ||
| Payment of issuance cost related to 2024 public offering of shares | — | (355) |
| Proceeds from long-term debt, net of issuance costs | — | 93,472 |
| Payments to taxing authorities in connection with shares directly withheld from employees | (1,706) | (1,776) |
| Proceeds from stock option exercises | 2,515 | 1,062 |
| Cash payment for performance stock units | — | (1,304) |
| Payment of issuance costs related to Series A Preferred Stock | — | (537) |
| Net cash provided by financing activities | 809 | 90,562 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (14) | 15 |
| Net decrease in cash, cash equivalents, and restricted cash | (15,275) | (15,195) |
| Cash, cash equivalents, and restricted cash | ||
| Beginning of period | 30,234 | 29,517 |
| End of period | $14,959 | $14,322 |
| Supplemental disclosure of cash flow information | ||
| Cash paid during the period for interest | $7,775 | $830 |
| Cash paid during the period for income taxes | — | 3 |
| Significant noncash activities | ||
| Accrued compensation paid in equity | $3,371 | $3,578 |
| Purchases of property and equipment included in accounts payable and other accrued liabilities | 1,022 | 468 |
| Settlement of warrants to equity | — | 190,060 |
| Conversion of preferred stock to common stock | — | 209,883 |
| Issuance costs included in accounts payable and other accrued liabilities | — | 654 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.